Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with Alzheimer disease: three randomized clinical trials

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - Jama, 2018 - jamanetwork.com
Importance New therapeutic approaches for Alzheimer disease (AD) are needed. Objective
To assess whether idalopirdine, a selective 5-hydroxytryptamine-6 receptor antagonist, is …
被引用次数：163 相关文章

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - 2018 - pubmed.ncbi.nlm.nih.gov
Importance New therapeutic approaches for Alzheimer disease (AD) are needed. Objective
To assess whether idalopirdine, a selective 5-hydroxytryptamine-6 receptor antagonist, is …
[HTML] nih.gov

[HTML][HTML] Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - JAMA, 2018 - ncbi.nlm.nih.gov
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients
With Alzheimer Disease - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

[引用][C] Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - JAMA, 2018 - cir.nii.ac.jp
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients
With Alzheimer Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - JAMA, 2018 - europepmc.org
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in
Patients With Alzheimer Disease: Three Randomized Clinical Trials. - Abstract - Europe PMC …

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo… - JAMA, 2018 - europepmc.org
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in
Patients With Alzheimer Disease: Three Randomized Clinical Trials. - Abstract - Europe PMC …